4
Changes in Ownership
Propanc Biopharma, Inc. Filed Acc 0001493152-19-007694
Options or other derivatives
- CEO, Acting CFO, Chairman acquired 58,500,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Nathanielsz James Andrew CEO, Acting CFO, Chairman | 2019-05-14 | Grant or award · Stock Options (Right to Buy) | +19,500,000 | 19,500,000 | D | ||
| Nathanielsz James Andrew CEO, Acting CFO, Chairman | 2019-05-14 | Grant or award · Restricted Stock Units | +19,500,000 | 19,500,000 | D | ||
| Nathanielsz James Andrew CEO, Acting CFO, Chairman | 2019-05-14 | Grant or award · Restricted Stock Units | +19,500,000 | 19,500,000 | D | ||
Loading xslF345X03/ownership.xml…